Compare ELTK & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTK | PYPD |
|---|---|---|
| Founded | 1970 | 2008 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 66.2M |
| IPO Year | 1997 | 2020 |
| Metric | ELTK | PYPD |
|---|---|---|
| Price | $9.45 | $3.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 31.0K | ★ 86.0K |
| Earning Date | 11-18-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $49,310,000.00 | N/A |
| Revenue This Year | $18.60 | N/A |
| Revenue Next Year | $9.04 | N/A |
| P/E Ratio | $54.17 | ★ N/A |
| Revenue Growth | ★ 2.54 | N/A |
| 52 Week Low | $7.65 | $2.30 |
| 52 Week High | $12.19 | $4.07 |
| Indicator | ELTK | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 58.21 |
| Support Level | $9.17 | $3.94 |
| Resistance Level | $9.80 | $4.07 |
| Average True Range (ATR) | 0.46 | 0.14 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 78.82 | 68.09 |
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.